These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Relevance of a prolonged preoperative antibiotic regime in the treatment of bisphosphonate-related osteonecrosis of the jaw. Hoefert S, Eufinger H. J Oral Maxillofac Surg; 2011 Feb; 69(2):362-80. PubMed ID: 21122968 [Abstract] [Full Text] [Related]
4. Bisphosphonate-related osteonecrosis of the jaw: clinical features, risk factors, management, and treatment outcomes of 26 patients. Thumbigere-Math V, Sabino MC, Gopalakrishnan R, Huckabay S, Dudek AZ, Basu S, Hughes PJ, Michalowicz BS, Leach JW, Swenson KK, Swift JQ, Adkinson C, Basi DL. J Oral Maxillofac Surg; 2009 Sep; 67(9):1904-13. PubMed ID: 19686928 [Abstract] [Full Text] [Related]
6. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. Bamias A, Kastritis E, Bamia C, Moulopoulos LA, Melakopoulos I, Bozas G, Koutsoukou V, Gika D, Anagnostopoulos A, Papadimitriou C, Terpos E, Dimopoulos MA. J Clin Oncol; 2005 Dec 01; 23(34):8580-7. PubMed ID: 16314620 [Abstract] [Full Text] [Related]
7. Bisphosphonate-related osteonecrosis of the jaws: a case series of 25 patients affected by osteoporosis. Manfredi M, Merigo E, Guidotti R, Meleti M, Vescovi P. Int J Oral Maxillofac Surg; 2011 Mar 01; 40(3):277-84. PubMed ID: 21163625 [Abstract] [Full Text] [Related]
8. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws. Carlson ER, Basile JD. J Oral Maxillofac Surg; 2009 May 01; 67(5 Suppl):85-95. PubMed ID: 19371819 [Abstract] [Full Text] [Related]
9. Serologic bone markers for predicting development of osteonecrosis of the jaw in patients receiving bisphosphonates. Lazarovici TS, Mesilaty-Gross S, Vered I, Pariente C, Kanety H, Givol N, Yahalom R, Taicher S, Yarom N. J Oral Maxillofac Surg; 2010 Sep 01; 68(9):2241-7. PubMed ID: 20728033 [Abstract] [Full Text] [Related]
10. A retrospective study evaluating frequency and risk factors of osteonecrosis of the jaw in 576 cancer patients receiving intravenous bisphosphonates. Thumbigere-Math V, Tu L, Huckabay S, Dudek AZ, Lunos S, Basi DL, Hughes PJ, Leach JW, Swenson KK, Gopalakrishnan R. Am J Clin Oncol; 2012 Aug 01; 35(4):386-92. PubMed ID: 22561331 [Abstract] [Full Text] [Related]
13. Tooth extraction in patients taking intravenous bisphosphonates: a preventive protocol and case series. Lodi G, Sardella A, Salis A, Demarosi F, Tarozzi M, Carrassi A. J Oral Maxillofac Surg; 2010 Jan 01; 68(1):107-10. PubMed ID: 20006163 [Abstract] [Full Text] [Related]
14. Bisphosphonate-related osteonecrosis of the jaws: a single-center study of 101 patients. Lazarovici TS, Yahalom R, Taicher S, Elad S, Hardan I, Yarom N. J Oral Maxillofac Surg; 2009 Apr 01; 67(4):850-5. PubMed ID: 19304045 [Abstract] [Full Text] [Related]
18. Bisphosphonate-related osteonecrosis of the jaws: a comprehensive review. Hewitt C, Farah CS. J Oral Pathol Med; 2007 Jul 01; 36(6):319-28. PubMed ID: 17559492 [Abstract] [Full Text] [Related]
19. Dental extractions in patient treated with intravenous bisphosphonates and risk of osteonecrosis of jaws: presentation of a preventive protocol and case series. Ferlito S, Liardo C, Puzzo S. Minerva Stomatol; 2010 Jul 01; 59(11-12):593-601. PubMed ID: 21217623 [Abstract] [Full Text] [Related]